Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fast Track Initiative

Investor type Venture Capital
Founders Hiromichi Kimura

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 22
Rounds per year 2.06
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 1
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Clinical Trials
Summary

Fast Track Initiative is the famous VC, which was founded in 2004. The leading representative office of defined VC is situated in the Tokyo. The company was established in Asia in Japan.

This organization was formed by Hiromichi Kimura.

Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2018.

The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - Japan. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Education, Life Science. Among the most popular portfolio startups of the fund, we may highlight AccuRna, Braizon Therapeutics, Inc., Modulus Discovery.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fast Track Initiative, startups are often financed by SMBC Venture Capital, SBI Investment, UTokyo Innovation Platform. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, UTokyo Innovation Platform, SBI Investment. In the next rounds fund is usually obtained by SMBC Venture Capital, SBI Investment, Mitsubishi UFJ Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fast Track Initiative:
Typical Co-investors
Fast Track Initiative is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fast Track Initiative:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

LUCA Science

Biotechnology
Health Care
Pharmaceutical
$35M06 Jun 2022 Chiyoda, Japan

Celsius Therapeutics

Biotechnology
Emergency Medicine
Genetics
Health Care
$83M24 Mar 2022 Cambridge, Massachusetts, United States

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$20M01 Mar 2022 Chiyoda, Japan

Sonire Therapeutics

Biotechnology
Health Care
Health Diagnostics
Medical
Wellness
$4M11 Jun 2021 Japan

Metagen Therapeutics

Biotechnology
Medical
$819K17 Mar 2021 Tsuruoka, Yamagata Prefecture, Japan

RIN Institute

Health Care
$1M19 Jan 2021 Chiyoda, Japan

LUCA Science

Biotechnology
Health Care
Pharmaceutical
$9M01 Sep 2020 Japan, Chiyoda

Modulus Discovery

Biotechnology
Clinical Trials
Pharmaceutical
$25M13 May 2020 Chiyoda, Japan

Mentalhealth Technologies

Health Care
Personal Health
$2M27 Apr 2020 Japan, Chiyoda

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fast Track Initiative?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: